Category: Research & Development
Medtech titan Medtronic says its Prestige cervical disc replacement system resulted in fewer follow-on surgeries and higher rates of overall patient success compared with spinal fusion.
Minnesota medtech titan Medtronic (NYSE:MDT) unveiled 7-year outcomes for patients undergoing artificial disc replacement, saying the procedure resulted in fewer revision surgeries than spinal fusion.
EnteroMedics unveils efficacy and safety results from the 1st 18 months of its 5-year ReCharge pivotal trial for its VBLOC neurostimulation therapy for treating obesity.
EnteroMedics (NSDQ:ETRM) revealed results for the 1st 18 months of its 5-year ReCharge pivotal trial for its VBLOC therapy, an implanted neurostimulator designed to help prevent obesity.
Neurosurgeon Dr. Philip Starr tells MassDevice.com about Medtronic's new Activa PC+S brain monitoring, recording and stimulating implant and its potential for treating neurological and psychiatric disease.
Deep-brain stimulation is about to get a major upgrade and medtech titan Medtronic (NYSE:MDT) is on the frontier, according to neurosurgeon Dr. Philip Starr.
Medtech giant Medtronic touts the 1st U.S. patients implanted with the next-generation Activa PC+S DBS system, which monitors and records brain activity while providing stimulation.
Medtech titan Medtronic (NYSE:MDT) announced today the 1st U.S. implants of its Activa PC+S deep brain stimulation system, which combines stimulation therapy with brain sensing and recording.
Sony's newly patented "SmartWig" technology, still under development, may feature every from brain-wave sensing technology to a laser pointer, according to patent documents.
MASSDEVICE ON CALL — Technology giant Sony Corp. (TYO:6758) filed patents this year for "SmartWig" technology, described as everything from standard health monitoring to a "presentation aid," MobiHealthNews reported.
A new study concludes that price-increases are "the culprit" in the ever-increasing cost of U.S. healthcare, dispelling the myth that increasing demand has driven higher spending.
A team of U.S. physicians joined forces to examine the rising cost of healthcare, concluding that rising prices play a major role in driving up national healthcare spending and that patients are ultimately getting the short end of the stick.
Minnesota medtech titan Medtronic's Valiant Mona LSA stent graft succeeds in a 1st-in-man FDA study.
Medtronic (NYSE:MDT) touted positive results for its Valiant Mona LSA stent graft, which succeeded in a proof-of-concept, 1st-in-man study conducted via the FDA's Innovation Pathway.